Private equity firm Veritas Capital is exploring a sale of Cotiviti Corp that could secure a valuation of over $15 billion for the healthcare analytics company, Bloomberg News reported on Tuesday, citing people with knowledge of the matter.
The firm had earlier been considering an IPO of Cotiviti, but is now weighing a sale due to a bout of volatility in the stock market, the report said.
Veritas declined to comment on the report.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
An official sales process could start as soon as January, the report added.
Cotiviti, which went public in 2016, was acquired by Veritas in 2018 in a take-private deal valued at $4.9 billion, as the PE firm looked to expand its Verscend healthcare IT business.
Source: Reuters
Can’t stop reading? Read more
Sports’ Saturday: Top sports news in private equity
Sports' Saturday: Top sports news in private equity Justin Ishbia, founder of private equity firm...
J.C. Flowers to retain control as Jefferson Capital launches $1.1bn Nasdaq IPO bid
J.C. Flowers to retain control as Jefferson Capital launches $1.1bn Nasdaq IPO bid J.C. Flowers...
Apollo and Irth Capital eye Papa John’s in $1.7bn take-private bid
Apollo and Irth Capital eye Papa John’s in $1.7bn take-private bid Apollo Global Management and...